Skip to main content
Focusing on frequent ASXL1 mutations in myeloid neoplasms, and considering rarer ASXL2 and ASXL3 mutations. Current medical research and opinion Oak, J. S., Ohgami, R. S. 2017: 1-2

View details for DOI 10.1080/03007995.2017.1284049

View details for PubMedID 28097878